Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET

[1]  D. Bowsher.  Termination of the central pain pathway in man: the conscious appreciation of pain. , 1957, Brain : a journal of neurology.

[2]  S. Snyder,et al.  Regional Distribution of Opiate Receptor Binding in Monkey and Human Brain , 1973, Nature.

[3]  Josef K. Wang.  Advances in Pain Research and Therapy , 1980 .

[4]  M. E. Lewis,et al.  Opiate receptor gradients in monkey cerebral cortex: correspondence with sensory processing hierarchies. , 1981, Science.

[5]  M. Zarbin,et al.  Distribution of opiate receptors in the monkey brain: An autoradiographic study , 1982, Neuroscience.

[6]  K. Berkley,et al.  Diencephalic mechanisms of pain sensation , 1985, Brain Research Reviews.

[7]  J. T. Murphy,et al.  Abnormal single-unit activity recorded in the somatosensory thalamus of a quadriplegic patient with central pain , 1987, Pain.

[8]  A. Bandura,et al.  Perceived self-efficacy and pain control: opioid and nonopioid mechanisms. , 1987, Journal of personality and social psychology.

[9]  G. Leijon,et al.  Central post-stroke pain — neurological symptoms and pain characteristics , 1989, Pain.

[10]  G. Leijon,et al.  Central post-stroke pain — a controlled trial of amitriptyline and carbamazepine , 1989, Pain.

[11]  D. Burchfield.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain , 1989 .

[12]  Karl J. Friston,et al.  The Relationship between Global and Local Changes in PET Scans , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  Gilles Defer,et al.  Central pain and thalamic hyperactivity: a single photon emission computerized tomographic study , 1991, Pain.

[14]  A. Beaudet,et al.  High resolution radioautographic localization of [125I]FK-33-824-labelled mu opioid receptors in the spinal cord of normal and deafferented rats , 1991, Neuroscience.

[15]  J. Ashburner,et al.  In vivo distribution of opioid receptors in man in relation to the cortical projections of the medial and lateral pain systems measured with positron emission tomography , 1991, Neuroscience Letters.

[16]  P. Roland.  Cortical representation of pain , 1992, Trends in Neurosciences.

[17]  B. Vogt,et al.  Nociceptive neurons in area 24 of rabbit cingulate cortex. , 1992, Journal of neurophysiology.

[18]  T J Spinks,et al.  Physical performance of a positron tomograph for brain imaging with retractable septa. , 1992, Physics in medicine and biology.

[19]  J. Mazziotta,et al.  Rapid Automated Algorithm for Aligning and Reslicing PET Images , 1992, Journal of computer assisted tomography.

[20]  M. Gabriel,et al.  Neurobiology of Cingulate Cortex and Limbic Thalamus , 1993 .

[21]  T. Jones,et al.  Spectral Analysis of Dynamic PET Studies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  B. Vogt,et al.  Anterior Cingulate Cortex and the Medial Pain System , 1993 .

[23]  John Ashburner,et al.  PARAMETRIC IMAGES OF C-11 DIPRENORPHINE BINDING USING SPECTRAL-ANALYSIS OF DYNAMIC PET IMAGES ACQUIRED IN 3D , 1993 .

[24]  T. Hökfelt,et al.  The effects of intrathecal neuropeptide Y on the spinal nociceptive flexor reflex in rats with intact sciatic nerves and after peripheral axotomy , 1994, Neuroscience.

[25]  S. Luthra,et al.  Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis. , 1994, British journal of rheumatology.

[26]  John Ashburner,et al.  Quantitation of [11C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer-only protocols , 1994, Journal of Neuroscience Methods.

[27]  Brent A. Vogt,et al.  Topography of diprenorphine binding in human cingulate gyrus and adjacent cortex derived from coregistered PET and MR images , 1995 .

[28]  D. Bowsher,et al.  The management of central post-stroke pain. , 1995, Postgraduate medical journal.

[29]  C. Hulsebosch,et al.  Mechanical and thermal allodynia in chronic central pain following spinal cord injury , 1996, Pain.

[30]  A. Morel,et al.  Low-threshold calcium spike bursts in the human thalamus. Common physiopathology for sensory, motor and limbic positive symptoms. , 1996, Brain : a journal of neurology.

[31]  T. Hökfelt,et al.  Central inhibitory dysfunctions: Mechanisms and clinical implications , 1997, Behavioral and Brain Sciences.

[32]  A. Craig.  A new version of the thalamic disinhibition hypothesis of central pain , 1998 .

[33]  A. K. Jones,et al.  The contribution of functional imaging techniques to our understanding of rheumatic pain. , 1999, Rheumatic diseases clinics of North America.

[34]  A. K. Jones,et al.  Measurement of Changes in Opioid Receptor Binding in Vivo During Trigeminal Neuralgic Pain Using [11C]Diprenorphine and Positron Emission Tomography , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  F. Benedetti,et al.  Somatotopic Activation of Opioid Systems by Target-Directed Expectations of Analgesia , 1999, The Journal of Neuroscience.

[36]  R. Llinás,et al.  Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Fournié-Zaluski,et al.  Analgesic doses of the enkephalin degrading enzyme inhibitor RB 120 do not have discriminative stimulus properties. , 2000, European journal of pharmacology.

[38]  D. Rowbotham.  Endogenous opioids, placebo response, and pain , 2001, The Lancet.

[39]  P Youell,et al.  Cortical processing of affective versus sensory-discriminative aspects of pain - a PET study , 2002 .

[40]  P. Rainville.  Brain mechanisms of pain affect and pain modulation , 2002, Current Opinion in Neurobiology.

[41]  B. Roques,et al.  Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone , 2003, Pain.

[42]  M. Rowbotham,et al.  Oral opioid therapy for chronic peripheral and central neuropathic pain. , 2003, The New England journal of medicine.